Sun et al. analyzed both the microenvironment of solid tumors and radiomic features to evaluate CD8+ cells in the tumor periphery and found a promising way to predict immune phenotypes and clinical outcomes for solid cancer patients [30]. This evidence concerns the gene CD8A and neoplasm.